Preclinical Pharmacokinetics, Pharmacodynamics, Tissue Distribution, and Interspecies Scaling of Recombinant Human Coagulation Factor XaI16L. 2017

Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
Biomedicine Design, Pfizer Research and Development, Andover, Massachussetts 01810. Electronic address: chuenlei.parng@pfizer.com.

FXaI16L is a recombinant human FXa variant which is currently being evaluated in the clinic for treating intracerebral hemorrhage. The aim of our studies is to investigate overall pharmacokinetics, pharmacodynamics, and distribution of FXaI16L in preclinical species, and to understand its potential implication in human. Pharmacokinetics of FXaI16L was examined using active site probes and the results showed that FXaI16L displayed fast clearance, low volume of distribution, and a very short plasma resident time in mice, rats, and monkeys. When pharmacodynamics was examined in monkeys, concentration effects of FXaI16L on shortening of active partial prothrombin time and formation of thrombin-antithrombin complex were observed. Furthermore, biodistribution study was conducted in mice using radiolabeled FXaI16L, and showed that 125I-FXaI16L has high plasma protein binding and significant liver and kidney distribution. Human pharmacokinetic prediction for first-in-human dosing was evaluated using allometric scaling, liver blood flow, and a fixed coefficient method, and single species allometric scaling using monkey data was most predictive for human pharmacokinetics of FXaI16L.

UI MeSH Term Description Entries
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
January 1996, Toxicology and applied pharmacology,
Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
January 1999, The Journal of pharmacology and experimental therapeutics,
Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
September 2007, Drug metabolism and disposition: the biological fate of chemicals,
Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
March 2008, International immunopharmacology,
Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
May 2010, Pharmaceutical research,
Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
November 1999, Drug metabolism and disposition: the biological fate of chemicals,
Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
January 2005, Toxicologic pathology,
Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
May 1995, American journal of therapeutics,
Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
June 1994, Clinical pharmacology and therapeutics,
Chuenlei Parng, and Victoria Markiewicz, and Jianqing Chen, and Beth Leary, and Nicole Duriga, and Lisa Dyleski, and Teresa Caiazzo, and Michael Bolt, and Alison Joyce, and Boris Gorovits, and Debra D Pittman, and Robert Webster
November 1996, Drug metabolism reviews,
Copied contents to your clipboard!